0001104659-22-004980.txt : 20220118
0001104659-22-004980.hdr.sgml : 20220118
20220118180109
ACCESSION NUMBER: 0001104659-22-004980
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220113
FILED AS OF DATE: 20220118
DATE AS OF CHANGE: 20220118
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Doshi Dipal
CENTRAL INDEX KEY: 0001613084
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40969
FILM NUMBER: 22536154
MAIL ADDRESS:
STREET 1: C/O AMICUS THERAPEUTICS
STREET 2: 1 CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Entrada Therapeutics, Inc.
CENTRAL INDEX KEY: 0001689375
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 813983399
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6 TIDE STREET
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 857-305-1825
MAIL ADDRESS:
STREET 1: 6 TIDE STREET
CITY: BOSTON
STATE: MA
ZIP: 02210
FORMER COMPANY:
FORMER CONFORMED NAME: CycloPorters, Inc.
DATE OF NAME CHANGE: 20161104
4
1
tm223204-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-01-13
0
0001689375
Entrada Therapeutics, Inc.
TRDA
0001613084
Doshi Dipal
C/O ENTRADA THERAPEUTICS, INC.
6 TIDE STREET
BOSTON
MA
02210
1
1
0
0
President and CEO
Common Stock
2022-01-13
4
M
0
10000
1.74
A
184460
D
Stock Option (Right to Buy)
1.74
2022-01-13
4
M
0
10000
0
D
2029-05-14
Common Stock
10000
399989
D
Consists of (i) 170,067 shares of common stock and (ii) 14,393 shares of restricted common stock issued upon early exercise of stock options.
25% of the shares subject to this option vested and became exercisable on December 31, 2019, with the remaining 75% vesting in 36 equal monthly installments thereafter.
/s/ Jared Cohen, as Attorney-in-Fact
2022-01-18